[IMRX] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[IMRX] Immuneering Corporation
Announcement Date
06-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- 1.59%
YoY- -15.51%
Quarter Report
IMRX's Result
IMRX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
Revenue 0 94,419 94 660 481 -
PBT -14,080 -12,189 -11,527 -7,987 -3,604 40.55%
Tax -0 -1,139 -52 1 1 -
NP -14,080 -12,189 -11,527 -7,988 -3,604 40.55%
Tax Rate - - - - - -
Total Cost 14,080 106,608 11,622 8,648 4,085 36.22%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
NP Margin 0.00 -12.91 -12,208.67 -1,210.18 -749.56 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
EPS -0.47 -0.43 -0.44 -0.33 -0.27 14.85%
EPS Diluted -0.47 -0.43 -0.44 -0.33 -0.27 14.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.